IL158893A0 - Method for preparing human immunolobulin concentrates for therapeutic use - Google Patents
Method for preparing human immunolobulin concentrates for therapeutic useInfo
- Publication number
- IL158893A0 IL158893A0 IL15889302A IL15889302A IL158893A0 IL 158893 A0 IL158893 A0 IL 158893A0 IL 15889302 A IL15889302 A IL 15889302A IL 15889302 A IL15889302 A IL 15889302A IL 158893 A0 IL158893 A0 IL 158893A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic use
- immunolobulin
- concentrates
- preparing human
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0106234A FR2824568B1 (fr) | 2001-05-11 | 2001-05-11 | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
PCT/FR2002/001407 WO2002092632A1 (fr) | 2001-05-11 | 2002-04-24 | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
IL158893A0 true IL158893A0 (en) | 2004-05-12 |
Family
ID=8863163
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15889302A IL158893A0 (en) | 2001-05-11 | 2002-04-24 | Method for preparing human immunolobulin concentrates for therapeutic use |
IL158893A IL158893A (en) | 2001-05-11 | 2003-11-16 | Method for preparing human immunolobulin concentrates for therapeutic use, involving chromatography on an anion exchange at an alkaline ph |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL158893A IL158893A (en) | 2001-05-11 | 2003-11-16 | Method for preparing human immunolobulin concentrates for therapeutic use, involving chromatography on an anion exchange at an alkaline ph |
Country Status (11)
Country | Link |
---|---|
US (1) | US7186410B2 (xx) |
EP (1) | EP1385886B1 (xx) |
JP (1) | JP4445202B2 (xx) |
AT (1) | ATE312120T1 (xx) |
CA (1) | CA2446704C (xx) |
DE (1) | DE60207848T2 (xx) |
DK (1) | DK1385886T3 (xx) |
ES (1) | ES2254676T3 (xx) |
FR (1) | FR2824568B1 (xx) |
IL (2) | IL158893A0 (xx) |
WO (1) | WO2002092632A1 (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2853551B1 (fr) | 2003-04-09 | 2006-08-04 | Lab Francais Du Fractionnement | Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee |
FR2895263B1 (fr) | 2005-12-26 | 2008-05-30 | Lab Francais Du Fractionnement | Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives |
EP1981540B1 (en) * | 2006-01-30 | 2013-03-20 | Grifols Therapeutics Inc. | Method of treatment and prophylaxis of diseases related to amyloid deposition using igm |
FR2899112B1 (fr) | 2006-03-31 | 2010-09-03 | Lab Francais Du Fractionnement | Concentre d'immunoglobulines et de fragments f (ab)'2 et/ou fab specifiques d'un arbovirus en tant que medicament. |
FR2899111B1 (fr) * | 2006-03-31 | 2010-09-03 | Lab Francais Du Fractionnement | Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament. |
US7794721B2 (en) * | 2006-12-13 | 2010-09-14 | Simon Michael R | Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith |
US8709413B2 (en) | 2006-12-13 | 2014-04-29 | Michael R. Simon | Treatment of celiac disease with IgA |
US7597891B2 (en) * | 2006-12-13 | 2009-10-06 | Simon Michael R | Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases |
US8119104B2 (en) * | 2006-12-13 | 2012-02-21 | Michael R. Simon | Treatment of celiac disease with IgA |
FR2939667B1 (fr) | 2008-12-17 | 2012-01-27 | Fractionnement Et Des Biotechonologies Lab Franc | Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo |
FR2940617B1 (fr) | 2008-12-30 | 2012-04-20 | Fractionnement Et Des Biotechonologies Lab Franc | Composition d'immunoglobulines g |
AU2010253830B2 (en) | 2009-05-27 | 2016-03-03 | Takeda Pharmaceutical Company Limited | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
FR2949195B1 (fr) | 2009-08-24 | 2011-10-14 | Lfb Biomedicaments | Poche de stockage de solution therapeutique |
US8304248B2 (en) * | 2009-11-16 | 2012-11-06 | Torres Anthony R | Protein separation via ion-exchange chromatography and associated methods, systems, and devices |
FR2952826B1 (fr) | 2009-11-20 | 2012-04-06 | Lab Francais Du Fractionnement | Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique |
IT1397061B1 (it) | 2009-12-28 | 2012-12-28 | Kedrion Spa | Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale. |
GB201006753D0 (en) | 2010-04-22 | 2010-06-09 | Biotest Ag | Process for preparing an immunolobulin composition |
US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
FR2961107B1 (fr) | 2010-06-15 | 2012-07-27 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines stabilisee |
FR2962650B1 (fr) * | 2010-07-19 | 2013-04-05 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
FR2974301B1 (fr) * | 2011-04-20 | 2013-08-23 | Lab Francais Du Fractionnement | Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes |
FR2977893B1 (fr) * | 2011-07-11 | 2015-02-20 | Lab Francais Du Fractionnement | Procede de preparation d'un concentre d'immunoglobulines polyvalentes |
TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之i-iv-1部分沉澱 |
IL274512B1 (en) | 2012-02-29 | 2024-03-01 | Baxalta Inc | IgG-stimulated remodeling of peripheral nerve myelin |
EP2636681A1 (en) * | 2012-03-09 | 2013-09-11 | CSL Behring AG | Process for enriching IgA |
MX360245B (es) | 2012-03-09 | 2018-10-26 | Csl Behring Ag | Composiciones que comprenden inmunoglobulinas de tipo secretor. |
EP2636684A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Prevention of infection |
CN105189530B (zh) * | 2013-02-28 | 2019-06-07 | 新加坡科技研究局 | 从缺乏染色质的细胞培养收获物中色谱纯化抗体 |
MX365501B (es) | 2013-03-14 | 2019-06-05 | Amgen Inc | Eliminacion de ligandos lixiviados de purificacion de afinidad. |
EP3004135A4 (en) * | 2013-06-04 | 2016-11-23 | Agency Science Tech & Res | PROCESS FOR CLEANING PROTEINS |
WO2015001277A1 (fr) * | 2013-07-05 | 2015-01-08 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Matrice de chromatographie d'affinité |
FR3018450B1 (fr) * | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
FR3035971A1 (fr) | 2015-05-07 | 2016-11-11 | Lab Francais Du Fractionnement | Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b |
CN105126100B (zh) * | 2015-09-23 | 2021-01-26 | 成都蓉生药业有限责任公司 | 一种富含IgM的人免疫球蛋白制剂及其制备方法 |
EP3275897A1 (en) * | 2016-07-27 | 2018-01-31 | Biotest AG | Process for preparing immunoglobulin compositions |
FR3064486A1 (fr) | 2017-03-31 | 2018-10-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures |
FR3064485A1 (fr) | 2017-03-31 | 2018-10-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Traitement d'une infection par le virus respiratoire syncytial |
FR3064484A1 (fr) | 2017-03-31 | 2018-10-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Composition d'immunoglobulines utiles pour traiter des infections virales |
CN108101981B (zh) * | 2018-01-15 | 2019-06-04 | 四川远大蜀阳药业有限责任公司 | 一种静注免疫球蛋白的生产工艺 |
FR3081328B1 (fr) | 2018-05-24 | 2021-01-01 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
EP4126930A1 (en) | 2020-03-31 | 2023-02-08 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation from c-1 inhibitor depleted plasma |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4305870A (en) * | 1979-01-31 | 1981-12-15 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Intravenous plasma derivatives and their production |
US4272521A (en) * | 1979-07-16 | 1981-06-09 | Cutter Laboratories, Inc. | Purified immune serum globulin |
DE3927112C1 (xx) * | 1989-08-17 | 1990-10-25 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
DE3927111C3 (de) * | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
ATE122054T1 (de) * | 1990-03-22 | 1995-05-15 | Biotest Pharma Gmbh | Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates. |
US5258177A (en) * | 1991-12-10 | 1993-11-02 | Alpha Therapeutic Corporation | IgA preparation and process of making the same |
FR2706466B1 (fr) * | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
DE4424935C1 (de) * | 1994-07-14 | 1996-03-21 | Immuno Ag | Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung |
US6150507A (en) * | 1995-03-23 | 2000-11-21 | Biopure Corporation | Method for producing a purified hemoglobin product |
US6096872A (en) * | 1997-10-14 | 2000-08-01 | Ortho Diagnostic Systems, Inc. | Viral clearance process |
JP4359352B2 (ja) * | 1997-10-23 | 2009-11-04 | 田辺三菱製薬株式会社 | 室温保存製剤 |
IL140155A (en) | 1998-06-09 | 2005-12-18 | Statens Seruminstitut | Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
-
2001
- 2001-05-11 FR FR0106234A patent/FR2824568B1/fr not_active Expired - Fee Related
-
2002
- 2002-04-24 EP EP02727688A patent/EP1385886B1/fr not_active Expired - Lifetime
- 2002-04-24 WO PCT/FR2002/001407 patent/WO2002092632A1/fr active IP Right Grant
- 2002-04-24 DE DE60207848T patent/DE60207848T2/de not_active Expired - Lifetime
- 2002-04-24 DK DK02727688T patent/DK1385886T3/da active
- 2002-04-24 AT AT02727688T patent/ATE312120T1/de active
- 2002-04-24 JP JP2002589515A patent/JP4445202B2/ja not_active Expired - Fee Related
- 2002-04-24 IL IL15889302A patent/IL158893A0/xx unknown
- 2002-04-24 ES ES02727688T patent/ES2254676T3/es not_active Expired - Lifetime
- 2002-04-24 CA CA2446704A patent/CA2446704C/fr not_active Expired - Fee Related
- 2002-04-24 US US10/476,771 patent/US7186410B2/en not_active Expired - Lifetime
-
2003
- 2003-11-16 IL IL158893A patent/IL158893A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2446704C (fr) | 2013-09-24 |
ATE312120T1 (de) | 2005-12-15 |
DE60207848D1 (de) | 2006-01-12 |
FR2824568A1 (fr) | 2002-11-15 |
EP1385886A1 (fr) | 2004-02-04 |
JP2005500265A (ja) | 2005-01-06 |
JP4445202B2 (ja) | 2010-04-07 |
US20040132979A1 (en) | 2004-07-08 |
DE60207848T2 (de) | 2006-08-17 |
FR2824568B1 (fr) | 2004-04-09 |
IL158893A (en) | 2009-08-03 |
US7186410B2 (en) | 2007-03-06 |
CA2446704A1 (fr) | 2002-11-21 |
EP1385886B1 (fr) | 2005-12-07 |
WO2002092632A1 (fr) | 2002-11-21 |
ES2254676T3 (es) | 2006-06-16 |
DK1385886T3 (da) | 2006-04-18 |
AU2002257887A2 (en) | 2002-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL158893A0 (en) | Method for preparing human immunolobulin concentrates for therapeutic use | |
EP0875563A3 (en) | Improved methods for processing activated protein C | |
AU2002350205A1 (en) | Apparatus, system and method for configuration of adaptive integrated circuitry having fixed, application specific computational elements | |
HK1037248A1 (en) | Method of executing microprocessor instructions, associated microprocessor and data processing system. | |
AU5719600A (en) | Method of obtaining protein isolates and concentrates from colostrum | |
IL157446A0 (en) | Increased recovery of active proteins | |
AU2002237945A1 (en) | Speech transcription, therapy, and analysis system and method | |
GB0100513D0 (en) | Process | |
EP1348961A4 (en) | PROTEIN CHIPS, METHOD OF MANUFACTURING THEREOF, AND PROBLEM SYSTEM FOR PROTEIN CHIPS AND OPERATING PROCESS FOR THE SEALING SYSTEM | |
EP1414474A4 (en) | PROTEIN BOWMAN BIRK HEMMER CONCENTRATE AND MANUFACTURING METHOD THEREFOR | |
WO2000048647A3 (en) | Apparatus for the dialysis of blood, method for fabricating the same, and method for the dialysis of blood | |
NO993424D0 (no) | Fremgangsmåte til selektiv nedbrytning av melkeprotein i naervaer av andre melkeproteiner | |
AU4188296A (en) | Processed whey protein | |
HK1048580A1 (en) | Method for treatment of chronic venous insufficiencies using an extract of red vine leaves. | |
AU2001257274A1 (en) | A method of treating soy proteins and a soy protein product produced by this method | |
AU2002338765A1 (en) | Method and system for processing fault hypotheses | |
ZA961450B (en) | A process for the preparation of factor ix from biological sources | |
UA27997C2 (uk) | Агент екстракції периплазматичного рекомбінантного білка, спосіб одержання периплазматичного рекомбінантного білка (варіанти), спосіб культивування прокаріотичного мікроорганізму | |
WO2002046475A3 (en) | Method of detecting and treating tuberous sclerosis complex associated disorders | |
AUPM885294A0 (en) | Chemically assisted protein annealing treatment | |
NZ332323A (en) | Chromatographic method for removing unconventional transmissible agents from a protein solution | |
AU2002248190A1 (en) | Method of complexing a protein by the use of a dispersed system and proteins thereof | |
WO2001090960A3 (en) | Methods for protein design | |
AU6477096A (en) | Method of solubilizing, purifying, and refolding protein | |
AU2001250780A1 (en) | System and method for internet anonymous id transactions |